162 results on '"Zhao, Zhongyun"'
Search Results
2. Preparation of the black rice starch-gallic acid complexes by ultrasound treatment: Physicochemical properties, multiscale structure, and in vitro digestibility
3. Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-based Study in South Korea
4. Economic burden of toxicities associated with treating metastatic melanoma in eight countries
5. The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options
6. Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison
7. Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab and Vemurafenib for the Treatment of Patients with Metastatic Melanoma
8. Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis
9. Major Surgery in Patients with Metastatic Colorectal Cancer in Western Europe
10. Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab
11. Economic Outcomes Associated with Switching Individuals with Schizophrenia between Risperidone and Olanzapine: Findings from a Large US Claims Database
12. Medication Treatment Patterns following Initiation on Olanzapine versus Risperidone: A Retrospective Analysis
13. Combining Opinion Surveys with Time-Series Data to Forecast the Japanese Economy
14. Equity in health care access to: assessing the urban health insurance reform in China
15. Systematic Review on Infusion Reactions Associated with Chemotherapies and Monoclonal Antibodies for Metastatic Colorectal Cancer
16. Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea
17. Treatment patterns of lipid‐lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
18. Urban employee health insurance reform and the impact on out-of-pocket payment in China
19. Bias reduction in estimating long-run relationships from dynamic heterogeneous panels
20. Estimating Years of Life Lost Due to Cardiovascular Disease in Japan
21. Characteristics of patients with dyslipidemia treated in routine care setting in China
22. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
23. Treatment patterns of lipid‐lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan.
24. Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
25. Stochastic Cost-Effectiveness Analysis: A Simultaneous Marginal-Effect Approach
26. Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States
27. Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
28. Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States
29. Medical Costs by Disease Stage in Medicare Patients with Metastatic Melanoma
30. Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison
31. Treatment patterns of metastatic melanoma in five European countries.
32. Prevalence of autoimmune comorbidities in patients with metastatic melanoma in the US.
33. Estimating healthcare resource use associated with the treatment of metastatic melanoma in eight countries
34. Economic burden of toxicities associated with treating metastatic melanoma in eight countries
35. Years of life lost due to metastatic melanoma in 12 countries
36. Current treatment patterns in patients with metastatic melanoma: A retrospective claims database analysis in the United States (US).
37. Overall survival in patients with metastatic melanoma
38. The Pattern and Cost of Palliative Surgeries in Patients with Metastatic Melanoma
39. Drug Pricing and Health Technology Assessment in China and Other Asian Markets
40. Treatment Patterns in Patients with Metastatic Melanoma: A Retrospective Analysis
41. Patterns of pharmaceutical therapy in advanced melanoma.
42. Current management of advanced melanoma: A European perspective.
43. Hospital Costs of Adverse Events in Patients with Metastatic Colorectal Cancer
44. The impact of infusion reactions associated with monoclonal antibodies in metastatic colorectal cancer: A European perspective
45. Surgery, radiation, and systemic therapies in patients with metastatic melanoma.
46. DTIC and GM-CSF in the treatment of patients with metastatic melanoma.
47. Performance status of patients with advanced melanoma over time in routine clinical practice.
48. Lines of systemic therapy in patients with metastatic melanoma in the United States.
49. Final skin toxicity (ST) and patient-reported outcomes (PRO) results from PRIME: A randomized phase III study of panitumumab (pmab) plus FOLFOX4 (CT) for first-line metastatic colorectal cancer (mCRC).
50. Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.